Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126298231 | 12629823 | 1 | I | 20160708 | 20160808 | 20160808 | PER | US-AMGEN-USASP2016089691 | AMGEN | 17.00 | YR | T | F | Y | 46.40000 | KG | 20160808 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126298231 | 12629823 | 1 | PS | NPLATE | ROMIPLOSTIM | 1 | Subcutaneous | 100 MUG, QWK | U | 125268 | 100 | UG | POWDER FOR INJECTION | /wk | |||||
| 126298231 | 12629823 | 2 | SS | NPLATE | ROMIPLOSTIM | 1 | Subcutaneous | 4 MUG/KG, QWK | U | 125268 | 4 | UG/KG | POWDER FOR INJECTION | /wk | |||||
| 126298231 | 12629823 | 3 | SS | NPLATE | ROMIPLOSTIM | 1 | Subcutaneous | 150 MUG, QWK | U | 125268 | 150 | UG | POWDER FOR INJECTION | /wk | |||||
| 126298231 | 12629823 | 4 | SS | NPLATE | ROMIPLOSTIM | 1 | Subcutaneous | 150 MUG, QWK | U | 125268 | 150 | UG | POWDER FOR INJECTION | /wk | |||||
| 126298231 | 12629823 | 5 | SS | NPLATE | ROMIPLOSTIM | 1 | Subcutaneous | 150 MUG, QWK | U | 125268 | 150 | UG | POWDER FOR INJECTION | /wk | |||||
| 126298231 | 12629823 | 6 | SS | NPLATE | ROMIPLOSTIM | 1 | Subcutaneous | 150 MUG, QWK | U | 125268 | 150 | UG | POWDER FOR INJECTION | /wk | |||||
| 126298231 | 12629823 | 7 | SS | NPLATE | ROMIPLOSTIM | 1 | Subcutaneous | 250 MUG, QWK | U | 125268 | 250 | UG | POWDER FOR INJECTION | /wk | |||||
| 126298231 | 12629823 | 8 | SS | NPLATE | ROMIPLOSTIM | 1 | Subcutaneous | 200 MUG, QWK | U | 125268 | 200 | UG | POWDER FOR INJECTION | /wk | |||||
| 126298231 | 12629823 | 9 | C | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Intravenous (not otherwise specified) | 1000 MG, UNK | 0 | 1000 | MG | ||||||||
| 126298231 | 12629823 | 10 | C | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | 50 G, UNK | 0 | 50 | G | |||||||||
| 126298231 | 12629823 | 11 | C | NORGESTIMATE AND ETHINYL ESTRADIOL | ETHINYL ESTRADIOLNORGESTIMATE | 1 | Oral | 90-20 MUG, UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126298231 | 12629823 | 1 | Immune thrombocytopenic purpura |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126298231 | 12629823 | Blood bilirubin abnormal | |
| 126298231 | 12629823 | Off label use | |
| 126298231 | 12629823 | Therapy non-responder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126298231 | 12629823 | 1 | 20160602 | 0 | ||
| 126298231 | 12629823 | 3 | 20160610 | 0 | ||
| 126298231 | 12629823 | 4 | 20160617 | 0 | ||
| 126298231 | 12629823 | 5 | 20160624 | 0 | ||
| 126298231 | 12629823 | 6 | 20160701 | 0 | ||
| 126298231 | 12629823 | 7 | 20160722 | 0 | ||
| 126298231 | 12629823 | 8 | 20160708 | 0 | ||
| 126298231 | 12629823 | 9 | 20160205 | 0 | ||
| 126298231 | 12629823 | 10 | 20160205 | 0 |